Depemokimab was shown to reduce exacerbations in patients with severe asthma. The proportions of adverse events of Depemokimab and the...

Patients with chronic pain from osteoarthritis who received LEVI-04 had a 50% reduction in pain from baseline. LEVI-04 was well...

A dose-dependent slowing in Huntington's disease progression was observed after 24 months in patients receiving high-dose AMT-130. The gene therapy...

Patients on pemvidutide experienced only 21.9% of weight loss attributable to lean mass. Pemvidutide preserves muscle tissue and prioritizes fat...

Patients with familial chylomicronemia syndrome (FCS) treated with plozasiran demonstrated a maximum reduction of 98% in triglyceride levels at month...

Patients with pancreatitis on high-dose Auxora showed a 2.1-day improvement in time to solid food tolerance compared to the placebo...

DB-OTO gene therapy has been shown to improve auditory response in children with congenital hearing loss DB-OTO is a promising...

Patients who received CT-388 had an average placebo-adjusted weight loss of 18.8%. CT-388 is well tolerated with only mild to...

Hemophilia B patients given Beqvez had a decreased incidence of total bleeding  Beqvez reduced the use of routine factor IX...

Gene therapy demonstrated clinically meaningful vision improvement in legally blind individuals. The therapy is capable of restoring vision even in...